Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

47 study records (showing up to 30 per record type)

• Registered trial NCT05814874 Not completed: Recruiting
  Improvement of the Selenium Supply in a Vegan Diet by Different Selenium Sources
  Condition or outcome area: Diet, Vegan|Selenium
  2023-04 · Subject: se; Selenium · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT06117436 Phase 2 / Phase 3 Not completed: Recruiting
  Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
  Condition or outcome area: Wound Heal
  2023-10-19 · Subject: se; Selenium · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05266794 Phase 4 Completed (results not assessed here)
  A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
  Condition or outcome area: Antioxidative Stress|End Stage Renal Disease on Dialysis
  2019-01-22 · Subject: se; Selenium · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05218577 Completed (results not assessed here)
  The Effect of High Selenium Functional Food and Selenium Supplement
  Condition or outcome area: Autism Spectrum Disorder
  2021-01-01 · Subject: se; Selenium · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03673995 Completed (results not assessed here)
  Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
  Condition or outcome area: Polycystic Ovary Syndrome|Menstrual Problem|Hirsutism
  2017-05-02 · Subject: (S)-Tyrosine; Tyrosine; L-Tyr; HSDB 2003; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; s4608; CS-8013; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04005222 Early_Phase 1 Completed (results not assessed here)
  Effects of Selenium and Melatonin on Ocular Ischemic Syndrome
  Condition or outcome area: Anterior Segment Ischemia (Diagnosis)
  2014-05 · Subject: Melatonin · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00784225 Phase 3 Completed (results not assessed here)
  S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
  Condition or outcome area: Cataract|Macular Degeneration
  2004-07 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00706121 Phase 3 Completed (results not assessed here)
  S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
  Condition or outcome area: Colorectal Cancer|Precancerous Condition
  2008-06 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00064194 Phase 3 Completed (results not assessed here)
  Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
  Condition or outcome area: Precancerous/Nonmalignant Condition|Prostate Cancer
  2001-11-28 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00063453 Phase 3 Completed (results not assessed here)
  Supplemental Selenium and Vitamin E and Pulmonary Function
  Condition or outcome area: Chronic Obstructive Pulmonary Disease|Lung Diseases|Lung Diseases, Obstructive
  2003-08 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00040378 Completed (results not assessed here)
  Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
  Condition or outcome area: Alzheimer Disease
  2002-05 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00006392 Phase 3 Completed (results not assessed here)
  S0000 Selenium and Vitamin E in Preventing Prostate Cancer
  Condition or outcome area: Prostate Cancer
  2001-07 · Subject: Vitamin E; T1539_SIGMA; NSC 82623; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; (+-)-alpha-Tocopherol; BRN 0094012; 5,7,8-Trimethyltocol; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-; T3634_SIGMA · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02767167 Completed (results not assessed here)
  Contribution of Cow's Milk to Iodine and Selenium Status in Women of Child-bearing Age
  Condition or outcome area: Selenium and Iodine Status
  2015-09 · Subject: Niu Ru; 牛乳; Cow Milk; Lac Bovis Seu Bubali · open the herb record · ClinicalTrials.gov
• Registered trial NCT00547547 Phase 1 Completed (results not assessed here)
  High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
  Condition or outcome area: Unspecified Adult Solid Tumor, Protocol Specific
  2006-04 · Subject: Jie Cai; 芥菜; India Mustard; Brassica Juncea · open the herb record · ClinicalTrials.gov
• Registered trial NCT02429921 Completed (results not assessed here)
  High-selenium Lentils Versus Arsenic Toxicity
  Condition or outcome area: Arsenic Poisoning
  2015-10 · Subject: Bing Dou; 兵豆; Co Mmon Lentil; Lens Culinaris · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42023494294 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of the association between selenium and osteoarthritis
  Condition or outcome area: Patients with osteoarthritis
  2023-12-27 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023493510 Registered protocol, no results here: Review Ongoing
  Effect of selenium supplementation on hemodialysis patients: a meta-analysis
  Condition or outcome area: Hemodialysis patients (HD) have high levels of oxidative stress and inflammation, which can subsequently lead to malnutrition. Some studies have shown that hemodialysis itself increases the production of free radicals. Among various nutritional elements, selenium is associated with patients with CKD. There is substantial evidence that selenium levels are reduced in patients with chronic kidney disease, especially those on hemodialysis. Selenium (Se) is an important trace mineral in the human bod
  2023-12-25 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023487978 Registered protocol, no results here: Review Ongoing
  Selenium Supplementation Effect On Thyroid Hormone In Critically Ill Patients With Non-thyroidal Illness: Systematic Review And Meta-Analysis
  Condition or outcome area: Non-thyroidal Illness (NTI) is a syndrome that occurs when serum thyroid hormone levels drop during starvation and illness. This only involves a decrease in serum triiodothyronine (T3) in mild illness. However, as the severity and length of the illness increase, there is also a decrease in both serum T3 and thyroxine (T4)
  2023-12-12 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023475750 Registered protocol, no results here: Review Ongoing
  Selenium and Atherosclerosis: a meta-analysis
  Condition or outcome area: Atherosclerosis is a leading cause of vascular disease worldwide. Its major clinical manifestations include ischemic heart disease, ischemic stroke, and peripheral arterial disease. Despite advances in controlling risk factors in many high-income countries, atherosclerotic cardiovascular disease now predominates in lower-income areas. The Global Burden of Disease study shows that world prevalence of ischemic heart disease has increased from about 100 million in 1990 to over 180 million cases in
  2023-11-08 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023452914 Registered protocol, no results here: Review Ongoing
  Selenium supplementation on TPOAb pregnant women: a meta-analysis of randomized controlled trials
  Condition or outcome area: Se supplementation is expected to improve inflammatory status in patients with autoimmune thyroiditis, especially in those with high activity, and has been demonstrated as effective in reducing the thyroid peroxidase antibodies titer. Se status seems to affect thyroid function in pregnancy, which prompts the potential role of Se supplementation in such patients. Some clinical trials have investigated the effectiveness of Se supplementation in pregnant women with thyroiditis, and their results su
  2023-08-19 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023452445 Registered protocol, no results here: Review Ongoing
  Efficacy of selenium in improving the outcomes of stroke patients: A systematic review of Randomized Clinical Trials.
  Condition or outcome area: Stroke is a leading cause of mortality, accounting for 11.8% of all deaths globally. It represents the second most common cause of death worldwide and a significant cause of long-term morbidity. Although the brain is incapable of regeneration, the element Selenium (Se) has been found to have a role in regenerating the antioxidant systems and improving cell proliferation and viability. So, Selenium can provide a promising solution for patients with ischemic and hemorrhagic stroke.
  2023-08-18 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023439196 Registered protocol, no results here: Review Ongoing
  The Effects of Selenium Supplementation on Cardiovascular Risk Factors Among Patients with Metabolic Diseases:A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Condition or outcome area: Metabolic syndrome is a group of clinical syndromes that are characterized by a combination of obesity, hyperglycemia, hypertension, and dyslipidemia. Patients with metabolic syndrome usually have cardiovascular risk factors, including disorders of glucolipid metabolism, inflammatory oxidative stress, and body weight and BMI, and are at high risk for developing cardiovascular disease. Selenium supplementation has been reported to improve cardiovascular risk factors in patients with metabolic dis
  2023-07-21 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023434801 Registered protocol, no results here: Review Ongoing
  Associations between dietary selenium intake and non-alcoholic fatty liver disease: a systematic review and meta-analysis
  Condition or outcome area: Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver, which can range from simple steatosis to more severe nonalcoholic steatohepatitis, and may eventually progress to liver cirrhosis, which is considered to be the main cause of chronic liver disease. Selenium is one of the necessary trace elements for human body, which plays an important role in the process of anti-oxidation and anti-inflammation. Therefore, dietary supplements containing selenium have been
  2023-06-24 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023431692 Registered protocol, no results here: Review Ongoing
  The Influence of Selenium on Telomere Length and DNA Damage as Indicators of Age-Related Changes: A Systematic Literature Review
  Condition or outcome area: Aging is a natural process accompanied by physiological changes and an increased risk of chronic diseases. Selenium, an essential mineral found in various foods, has been studied for its antioxidant properties and potential anti-aging effects. The review focuses on non-epigenetic biomarkers such as telomere length and DNA damage to assess age-related changes at the genomic and cellular levels.
  2023-06-12 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023424920 Registered protocol, no results here: Review Ongoing
  Selenium supplementation in cardiac surgery- A way to reduce post operative complications? A Systematic Review and Meta Analysis.
  Condition or outcome area: Postoperative outcomes of cardiac surgery have been evaluated in our meta analysis.
  2023-05-19 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023418840 Registered protocol, no results here: Review Completed published
  Efficacy and safety of the administration of selenium or vitamin E alone or combined administration in ICU patients: a systematic review and meta-analysis
  Condition or outcome area: The patients admitted to the intensive care unit are all kinds of critical acute diseases, such as those who need to be monitored after major surgery, anesthesia accidents, severe combined trauma, acute circulatory failure, acute respiratory failure, resuscitation after cardiac and respiratory arrest, electric shock, resuscitation after drowning, various poisoning patients, various shock patients, sepsis, amniotic fluid embolism, severe pregnancy toxemia, etc.
  2023-04-30 · Subject: Vitamin e; Alpha-Tocopherol; alpha-Tocopherol; 59-02-9; D-alpha-Tocopherol; 5,7,8-Trimethyltocol; (+)-alpha-Tocopherol; 2074-53-5; alpha Tocopherol; Phytogermine · open the ingredient record
• Systematic review registration CRD42023418840 Registered protocol, no results here: Review Completed published
  Efficacy and safety of the administration of selenium or vitamin E alone or combined administration in ICU patients: a systematic review and meta-analysis
  Condition or outcome area: The patients admitted to the intensive care unit are all kinds of critical acute diseases, such as those who need to be monitored after major surgery, anesthesia accidents, severe combined trauma, acute circulatory failure, acute respiratory failure, resuscitation after cardiac and respiratory arrest, electric shock, resuscitation after drowning, various poisoning patients, various shock patients, sepsis, amniotic fluid embolism, severe pregnancy toxemia, etc.
  2023-04-30 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023417585 Registered protocol, no results here: Review Ongoing
  Selenium intake and multiple health-related outcomes: an umbrella review of meta-analyses.
  Condition or outcome area: All health outcomes that involved the use of any types of selenium intake.
  2023-04-26 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023409554 Registered protocol, no results here: Review Ongoing
  The effects of selenium supplementation on glycemic parameters in adults: A systematic review and dose-response meta-analysis
  Condition or outcome area: Healthy, overweight or obese individuals, and those with any metabolic non-communicable disease such ascardiovascular disorders dyslipidemia, hypercholesterolemia, metabolic syndrome
  2023-03-31 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023405116 Registered protocol, no results here: Review Ongoing
  Selenium supplementation decreases CRP, IL-6 and TNF-alpha: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: The studies which were carried out in all health conditions and we will perform subgroup analysis for assessing the effect of selenium on each health condition.
  2023-03-15 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023445848 Registered protocol, no results here: Review Ongoing
  Effects of Vitamin D Supplementation on Autoantibodies and Thyroid Function in Patients with Hashimoto's Thyroiditis: A Systematic Review and Meta-analysis
  Condition or outcome area: Hashimoto's thyroiditis (HT) is the prevailing form of autoimmune thyroiditis and the leading cause of hypothyroidism in iodine-sufficient regions worldwide. The etiology of HT remains uncertain but is currently attributed to genetic susceptibility and environmental factors, including excessive iodine intake, selenium deficiency, viral infections (such as hepatitis C virus), vitamin D deficiency, and others. In HT patients, serum 25-hydroxyvitamin D [25(OH)D] levels were consistently lower compa
  2023-08-10 · Subject: Vitamin d2; Ergocalciferol; ergocalciferol; Calciferol; Viosterol; 50-14-6; Ergorone; Deltalin; Drisdol; Ostelin · open the ingredient record
• Systematic review registration CRD42023445848 Registered protocol, no results here: Review Ongoing
  Effects of Vitamin D Supplementation on Autoantibodies and Thyroid Function in Patients with Hashimoto's Thyroiditis: A Systematic Review and Meta-analysis
  Condition or outcome area: Hashimoto's thyroiditis (HT) is the prevailing form of autoimmune thyroiditis and the leading cause of hypothyroidism in iodine-sufficient regions worldwide. The etiology of HT remains uncertain but is currently attributed to genetic susceptibility and environmental factors, including excessive iodine intake, selenium deficiency, viral infections (such as hepatitis C virus), vitamin D deficiency, and others. In HT patients, serum 25-hydroxyvitamin D [25(OH)D] levels were consistently lower compa
  2023-08-10 · Subject: Vitamin d; 24,25-Dihydroxyvitamin D; (3R,6R)-6-[(1R,3aS,7aR)-4-[2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; (6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol; 24,25-dihydroxyvitamin D3; 24,25-Dihydroxycholecalciferol; 24,25-dihydroxyvitamin; CHEBI:89324; Q27161510; (3b,5Z,7E)-9,10-Secocholesta-5, · open the ingredient record
• Systematic review registration CRD42023469280 Registered protocol, no results here: Review Ongoing
  The role of minerals in ischemic heart disease
  Condition or outcome area: Ischemia is defined as inadequate blood supply (circulation) to a local area due to blockage of the blood vessels supplying the area. Ischemic means that an organ (e.g., the heart) is not getting enough blood and oxygen. Ischemic heart disease, also called coronary heart disease (CHD) or coronary artery disease, is the term given to heart problems caused by narrowed heart (coronary) arteries that supply blood to the heart muscle. Although the narrowing can be caused by a blood clot or by constri
  2023-12-22 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023468700 Registered protocol, no results here: Review Ongoing
  Micronutrient status and psychiatric disorders: Mendelian randomization and umbrella review
  Condition or outcome area: Major psychiatric disorders will be studied, including: depressive disorder, an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. Schizophrenia, a disorder of psychotic depth characterized by delusion formation, hallucinations, emotional disharmony, and regressive behavior. autism spectrum disorder, a childhood disorder characterized by markedly abnormal or impaired development in social interaction and communication and a markedly rest
  2023-10-13 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023430805 Registered protocol, no results here: Review Completed not published
  Role of antioxidant therapy in the treatment and prognosis of COVID-19: a systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: COVID-19 (viral respiratory illness) and its clinical consequences (i.e. time to recovery, overall mortality, ICU and hospital stays) will be studied.
  2023-06-05 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023441257 Registered protocol, no results here: Review Ongoing
  Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: A systematic review and network meta-analysis
  Condition or outcome area: Polycystic ovary syndrome (PCOS) is a common gynecological Endocrine disease, affecting about 8% -15% of women of childbearing age. PCOS is a heterogeneous disease characterized by a combination of signs and symptoms of androgen excess and ovarian dysfunction. The pathogenesis of PCOS may be related to factors such as hyperandrogenism, insulin resistance, obesity, metabolic abnormalities, and inflammation. Patients with PCOS have a higher risk of type 2/gestational diabetes, Atherosclerosis Dysl
  2023-07-11 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023422481 Registered protocol, no results here: Review Ongoing
  Microelements supplements on intermediate-disease markers: a network meta-analysis of randomized controlled trials
  Condition or outcome area: Globally, overweight and obesity have become an epidemic, both in adults and children, and the trend is increasing year by year and overweight have a higher risk of cardiovascular disease. Intermediate disease markers work in the human body, and it's changes can reflect the changes of some diseases in the human body , including cardiovascular disease. Trace elements are minerals that less than 0.01% of the human body weight , daily need is small, but essential to the human body. Among them, esse
  2023-05-20 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023417473 Registered protocol, no results here: Review Ongoing
  Comparative effects of nutritional supplements on adipokines, oxidative stress and inflammatory markers in adults with metabolic syndrome: a network meta-analysis of randomized controlled trials
  Condition or outcome area: Metabolic syndrome(including hypertension, hyperglycemia, hyperlipidemia, obesity, insulin resistance)
  2023-04-26 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023476001 Registered protocol, no results here: Review Ongoing
  The impact of dietary selenium supplementation on liver: a systematic review
  Condition or outcome area: This systematic review aims to analyze the effects of selenium supplementation im human liver. Given the antioxidant properties of selenium, the addition of this element in the diet can prevent damage to hepatocytes. These injuries are detected by measuring serum enzymes released in liver cell rupture. Such enzymes act as markers and provide information about the extent, magnitude and course of the lesion, which can be characterized by tenderness and abdominal pain. Among the enzymes, there are
  2023-11-08 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023418453 Registered protocol, no results here: Review Ongoing
  Heavy metals and trace elements in association with oxidative stress in women with polycystic ovary syndrome: a systematic review.
  Condition or outcome area: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies with multifactorial etiology. Oxidative stress is known to be one of the pathways involved in PCOS pathogenesis and its metabolic associations. Serum levels of heavy metals and trace elements can change in PCOS women and can be associated with oxidative stress.
  2023-04-29 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023483534 Registered protocol, no results here: Review Ongoing
  The effectiveness of nutrition supplements in improving in women with polycystic ovary syndrome: A systematic review and network meta-analysis.
  Condition or outcome area: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries. 4–10% of reproductive-age women are predicted to have PCOS worldwide. The pathophysiology of PCOS is chiefly concerned with hormonal imbalance, chronic low-grade inflammation, insulin resistance, and hyperandrogenism, which impair folliculogenesis and increase the risk of related comorbidities. Several clinical s
  2023-11-27 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023449705 Registered protocol, no results here: Review Ongoing
  Clinical Comparative Efficacy and Therapeutic Strategies for the Hashimoto's Thyroiditis: a Systematic Review and Network Meta-analysis.
  Condition or outcome area: Hashimoto’s thyroiditis (HT) is an autoimmune disease that destroys thyroid cells by cell and elevating thyroid autoantibody levels at an early stage, which has gradually become the main cause of hypothyroidism. The incidence of HT worldwide is serious, about 0.3–1.5 cases per 1000 people, which is one of the most common chronic autoimmune thyroiditis. The disease is more likely to affect women than men, most often in middle-aged women, and the risk of its development increases with age. Moreove
  2023-08-08 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42023360756 Registered protocol, no results here: Review Ongoing
  Selenium supplementation in Hashimoto's thyroiditis: a systematic review and meta-analysis of clinical and therapeutic impacts on subclinical autoimmune hypothyroidism
  Condition or outcome area: In Hashimoto's Thyroiditis (HT), occurs inflammation and thyroid interstitial infiltration of mononuclear hematopoietic cells, mainly lymphocytic. Organized in ectopic follicles, with cortical T-cells and central B-cells, they mediate the destruction of thyrocytes by emperipolesis. Therefore, autoantibodies (aAb) to thyroperoxidase (anti-TPO) and thyroglobulin (anti-TG) arise from the metabolic cytotoxicity of hydrogen peroxide - a substrate for the biosynthesis of tetraiodothyronine (T4) - whic
  2023-03-28 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42022383669 Registered protocol, no results here: Review Ongoing
  Selenium for the prevention of preterm birth: a systematic review
  Condition or outcome area: Every year, nearly 15 million babies are born preterm (before 37 completed weeks of gestation). Preterm birth is the leading cause of death in children under 5 globally, with 35% of neonatal deaths occurring due to complications associated with preterm birth. The burden of preterm birth is greatest in limited-resource settings with ~80% of preterm births occurring in Africa and South Asia. Preterm babies are at increased risk of short- and long-term adverse health outcomes, including chronic lun
  2022-12-23 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Systematic review registration CRD42022383160 Registered protocol, no results here: Review Ongoing
  Effects of Selenium Supplementation on Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis on Randomized Clinical Trials
  Condition or outcome area: POLYCYSTIC OVARY SYNDROME (PCOS) is a common gynecological endocrine disease, which affects 5-20% women of reproductive age worldwide. Its harm is not limited to infertility and abnormal menstruation, but also brings economic burden and long-term health risks to patients. Studies have shown that patients with PCOS often have insulin resistance and abnormal lipid metabolism.In addition, patients with PCOS have oxidative stress. Excessive oxidative stress and depletion of antioxidants may contribu
  2022-12-21 · Subject: Se; Selenium; 7782-49-2; Elemental selenium; SELENIUM ATOM; Selenium, elemental; Selenium hydride; Selenium elemental; Gray selenium; Selenium, metallic · open the ingredient record
• Publication PMID 33248145 Research model: Cell Experiment
  Selenium enrichment improves anti-proliferative effect of oolong tea extract on human hepatoma HuH-7 cells
  Food Chem Toxicol · 2021 · Subject: Wu Long Cha; 乌龙茶; Oolong Tea; Camellia Sinensis Var. Viridis · open the herb record · DOI 10.1016/j.fct.2020.111873
• Publication PMID 21855911 Research model: Animal Experiment
  The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth
  J Urol · 2011 · Subject: Lycopene; 502-65-8; all-trans-Lycopene; Psi,psi-carotene; trans-Lycopene; Lycopene 7; lycored; Redivivo; Mexoryl SAQ; Tomat-O-Red · open the ingredient record · DOI 10.1016/j.juro.2011.05.049